Outset Medical Net Income
| OM Stock | USD 4.54 0.16 3.40% |
As of the 12th of February 2026, Outset Medical holds the Variance of 70.67, coefficient of variation of (835.21), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Outset Medical, as well as the relationship between them. Please check Outset Medical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Outset Medical is priced some-what accurately, providing market reflects its current price of 4.54 per share. Given that Outset Medical has information ratio of (0.13), we recommend you to check out Outset Medical's recent market performance to make sure the company can sustain itself at a future point.
Outset Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.0691 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -115.2 M | -120.9 M | |
| Net Loss | -146.7 M | -154 M | |
| Net Loss | -115.2 M | -120.9 M | |
| Net Loss | (5.37) | (5.64) | |
| Net Income Per E B T | 1.01 | 0.80 |
Outset | Net Income | Build AI portfolio with Outset Stock |
Evaluating Outset Medical's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Outset Medical's fundamental strength.
Latest Outset Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Outset Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Outset Medical financial statement analysis. It represents the amount of money remaining after all of Outset Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Outset Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Outset Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (127.98 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Outset Net Income Regression Statistics
| Arithmetic Mean | (86,399,807) | |
| Coefficient Of Variation | (52.34) | |
| Mean Deviation | 40,903,420 | |
| Median | (49,780,000) | |
| Standard Deviation | 45,222,716 | |
| Sample Variance | 2045.1T | |
| Range | 123M | |
| R-Value | (0.81) | |
| Mean Square Error | 739.3T | |
| R-Squared | 0.66 | |
| Significance | 0.000072 | |
| Slope | (7,281,452) | |
| Total Sum of Squares | 32721.5T |
Outset Net Income History
Other Fundumenentals of Outset Medical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Outset Medical Net Income component correlations
Outset Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Outset Medical is extremely important. It helps to project a fair market value of Outset Stock properly, considering its historical fundamentals such as Net Income. Since Outset Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Outset Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Outset Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Outset diversify its offerings? Factors like these will boost the valuation of Outset Medical. Anticipated expansion of Outset directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Outset Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.56) | Revenue Per Share | Quarterly Revenue Growth 0.027 | Return On Assets | Return On Equity |
Outset Medical's market price often diverges from its book value, the accounting figure shown on Outset's balance sheet. Smart investors calculate Outset Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Outset Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Outset Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Outset Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Outset Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Outset Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Outset Medical.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Outset Medical on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Outset Medical or generate 0.0% return on investment in Outset Medical over 90 days. Outset Medical is related to or competes with SANUWAVE Health,, Helius Medical, Nano X, Inogen, Quanterix Corp, Perspective Therapeutics, and Viemed Healthcare. Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis More
Outset Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Outset Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Outset Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 50.58 | |||
| Value At Risk | (10.93) | |||
| Potential Upside | 9.51 |
Outset Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Outset Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Outset Medical's standard deviation. In reality, there are many statistical measures that can use Outset Medical historical prices to predict the future Outset Medical's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (2.01) | |||
| Treynor Ratio | (3.70) |
Outset Medical February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (3.69) | |||
| Mean Deviation | 5.03 | |||
| Coefficient Of Variation | (835.21) | |||
| Standard Deviation | 8.41 | |||
| Variance | 70.67 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (2.01) | |||
| Treynor Ratio | (3.70) | |||
| Maximum Drawdown | 50.58 | |||
| Value At Risk | (10.93) | |||
| Potential Upside | 9.51 | |||
| Skewness | (2.42) | |||
| Kurtosis | 15.58 |
Outset Medical Backtested Returns
As of now, Outset Stock is relatively risky. Outset Medical maintains Sharpe Ratio (i.e., Efficiency) of 0.0193, which implies the firm had a 0.0193 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Outset Medical, which you can use to evaluate the volatility of the company. Please check Outset Medical's Risk Adjusted Performance of (0.09), coefficient of variation of (835.21), and Variance of 70.67 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. Outset Medical has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, Outset Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Outset Medical is expected to be smaller as well. Outset Medical right now holds a risk of 5.87%. Please check Outset Medical treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Outset Medical will be following its historical price patterns.
Auto-correlation | -0.26 |
Weak reverse predictability
Outset Medical has weak reverse predictability. Overlapping area represents the amount of predictability between Outset Medical time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Outset Medical price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Outset Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.35 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Outset Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Outset Medical reported net income of (127.98 Million). This is 137.5% lower than that of the Health Care Equipment & Supplies sector and 153.75% lower than that of the Health Care industry. The net income for all United States stocks is 122.41% higher than that of the company.
Outset Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Outset Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Outset Medical could also be used in its relative valuation, which is a method of valuing Outset Medical by comparing valuation metrics of similar companies.Outset Medical is currently under evaluation in net income category among its peers.
Outset Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Outset Medical from analyzing Outset Medical's financial statements. These drivers represent accounts that assess Outset Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Outset Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 2.1B | 1.2B | 268.3M | 57.7M | 66.3M | 63.0M | |
| Enterprise Value | 2.2B | 2.0B | 1.3B | 336.0M | 386.3M | 367.0M |
Outset Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Outset Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Outset Medical's managers, analysts, and investors.Environmental | Governance | Social |
Outset Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Outset Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Outset Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Outset Medical's value.| Shares | Marshall Wace Asset Management Ltd | 2025-06-30 | 521.4 K | Pura Vida Investments, Llc | 2025-06-30 | 429.1 K | Geode Capital Management, Llc | 2025-06-30 | 415.6 K | Ensign Peak Advisors Inc | 2025-06-30 | 314.5 K | Schonfeld Strategic Advisors Llc | 2025-06-30 | 256.7 K | Northern Trust Corp | 2025-06-30 | 249.4 K | State Street Corp | 2025-06-30 | 205.3 K | Catalio Capital Management, Lp | 2025-06-30 | 166.7 K | Millennium Management Llc | 2025-06-30 | 158.5 K | Fmr Inc | 2025-06-30 | 2.6 M | Partner Fund Management Lp | 2025-06-30 | 1.7 M |
Outset Fundamentals
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | 8.29 M | ||||
| Shares Outstanding | 18.15 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 97.30 % | ||||
| Number Of Shares Shorted | 2.29 M | ||||
| Price To Book | 0.61 X | ||||
| Price To Sales | 0.71 X | ||||
| Revenue | 113.69 M | ||||
| Gross Profit | 45.32 M | ||||
| EBITDA | (97.89 M) | ||||
| Net Income | (127.98 M) | ||||
| Cash And Equivalents | 227.52 M | ||||
| Cash Per Share | 4.71 X | ||||
| Total Debt | 201.86 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 6.24 X | ||||
| Book Value Per Share | 7.78 X | ||||
| Cash Flow From Operations | (116.3 M) | ||||
| Short Ratio | 1.38 X | ||||
| Earnings Per Share | (11.56) X | ||||
| Price To Earnings To Growth | 0.06 X | ||||
| Target Price | 11.75 | ||||
| Number Of Employees | 354 | ||||
| Beta | 2.08 | ||||
| Market Capitalization | 85.32 M | ||||
| Total Asset | 275.8 M | ||||
| Retained Earnings | (1.09 B) | ||||
| Working Capital | 212.84 M | ||||
| Net Asset | 275.8 M |
About Outset Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Outset Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Outset Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Outset Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Health Care Equipment & Supplies sector continue expanding? Could Outset diversify its offerings? Factors like these will boost the valuation of Outset Medical. Anticipated expansion of Outset directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Outset Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.56) | Revenue Per Share | Quarterly Revenue Growth 0.027 | Return On Assets | Return On Equity |
Outset Medical's market price often diverges from its book value, the accounting figure shown on Outset's balance sheet. Smart investors calculate Outset Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Outset Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Outset Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Outset Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.